Neumora Therapeutics, Inc. (NMRA) Reports In-Line Q1 EPS

Neumora Therapeutics, Inc. (NASDAQ: NMRA) reported Q1 EPS of ($0.30), in-line with the analyst estimate of ($0.30).

For earnings history and earnings-related data on Neumora Therapeutics, Inc. (NMRA) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance